$41.7 million in cash and cash equivalents as of September 30, 2022; extends runway through December 2023 Mino-Lok® Phase…
Author: admin
Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application for Valbenazine as a Treatment for Chorea Associated with Huntington Disease
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that the U.S. Food and Drug…
Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative…
Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies
Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, through…
NOTICE – CHEMISTREE CONVERTIBLE DEBENTURE INTEREST PAYMENT
Chemistree Technology Inc. (CSE: CHM) (USOTCQB: CHMJF) (the “Company” or “Chemistree“), is providing Notice of the semi-annual…
Deka Biosciences, Inc Announces Submission of Investigational New Drug (IND) Application for Lead Oncology Asset, DK210 (EGFR)
Today, Deka Biosciences, Inc. (Deka), a biotech company focused on developing novel cytokine therapies to treat…
Bone Growth Stimulators Market Research Report by Product, Application, Distribution Channel, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19
The Global Bone Growth Stimulators Market size was estimated at USD 2,189.34 million in 2021 and expected to…
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to…
Mirati Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial-stage targeted oncology company, today announced that the Company will present at…
ATI Physical Therapy Names Healthcare Partnerships Leader Scott Gregerson as Chief Growth Officer
ATI Physical Therapy, Inc. (“ATI” or the “Company”) (NYSE: ATIP), the largest single-branded outpatient physical therapy provider in the United…